Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.36
-0.07 (-1.20%)
Nov 11, 2026, 4:08 PM HKT

HKG:0719 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
228.71289.89470.02496.51411.06348.55
Depreciation & Amortization
587.52587.52540.95516.94489.4438.58
Other Amortization
4.354.354.733.322.752.48
Loss (Gain) From Sale of Assets
-1.99-1.99-1.42-8.73-5.54-2.07
Asset Writedown & Restructuring Costs
1.111.115.12-33.26-39.29-84.79
Loss (Gain) From Sale of Investments
-7.76-7.76-9.84-9.58-8.36-8.02
Provision & Write-off of Bad Debts
6.26.28.4910.735.242.32
Other Operating Activities
18.8198.0993.93121.24122.3797.65
Change in Accounts Receivable
-547.75-547.75-629.94-423.54-717.33-751.07
Change in Inventory
-92.83-92.83-11.43-120.86-200.1476.18
Change in Accounts Payable
184.72184.72-153.63-332.39632.33121.63
Change in Other Net Operating Assets
12.5212.5235.8853.0745.83.96
Operating Cash Flow
393.27533.73367.61265.28758.24259.12
Operating Cash Flow Growth
-9.67%45.19%38.57%-65.01%192.63%-38.33%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-82.84-115.6-212.42-325.13-244.76-249.23
Sale of Property, Plant & Equipment
0.840.770.6511.867.942.43
Investment in Securities
1.531.53-8.63---
Other Investing Activities
10.249.88.188.177.929.11
Investing Cash Flow
-70.23-103.5-212.21-305.11-228.9-237.69

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Issued
-979.8860.31862.43833.79551.41
Long-Term Debt Repaid
--1,114-554.05-888.15-1,106-603.48
Lease Payments
-1.84-1.84-1.99-2.7-17.69-43.74
Net Debt Issued (Repaid)
-293.85-133.72306.26-25.72-272.57-52.07
Issuance of Common Stock
45.9453.1763.266.02274.6932.97
Common Dividends Paid
-139.02-209.78-225.85-175.9-163.01-148.43
Other Financing Activities
35.64-0.841.11-0.530.2427.8
Financing Cash Flow
-351.3-291.13184.78-196.11-130.66-139.73

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-8.787.2415.016.8615.69-7.87
Net Cash Flow
-37.04146.33355.19-229.08414.37-126.17

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
310.43418.13155.19-59.85513.489.89
Free Cash Flow Growth
15.42%169.43%--5092.02%-92.94%
Free Cash Flow Margin
3.85%4.78%1.83%-0.74%6.84%0.15%
Free Cash Flow Per Share
0.450.600.23-0.090.770.02
Levered Free Cash Flow
397.37654.46551.1250.07779.34222.79
Unlevered Free Cash Flow
421.68680.98575.9675.79810.41255.98
Free Cash Flow After Leases
308.6416.29153.2-62.55495.79-33.85

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
153.94142.596.2239.7966.2544.5
Change in Working Capital
-443.67-443.67-744.37-831.87-219.39-535.59